back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-05 16:51 Tx date 2024-04-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-5,509.666
-694 vol $7.94 each |
11,940 | |
| Filed 2024-03-27 16:16 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$994,399
+110,000 vol $9.04 each |
1,722,500 | |
| Filed 2024-03-05 13:34 Tx date 2024-03-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-6,232.12
-694 vol $8.98 each |
12,634 | |
| Filed 2024-02-06 19:10 Tx date 2024-01-16 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,549
+1,718 vol $3.23 each |
15,740 | |
| Filed 2024-02-06 19:09 Tx date 2024-01-16 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-5,549.14
-1,718 vol $3.23 each |
1,685,782 | |
| Filed 2024-02-06 19:04 Tx date 2024-01-16 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-17,180
-1,718 vol $10.00 each |
14,022 | |
| Filed 2024-02-06 19:04 Tx date 2024-01-16 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,549
+1,718 vol $3.23 each |
||
| Filed 2024-02-06 18:59 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,615
+500 vol $3.23 each |
13,328 | |
| Filed 2024-02-06 18:56 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-1,615
-500 vol $3.23 each |
1,685,282 | |
| Filed 2024-02-06 18:53 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,615
+500 vol $3.23 each |
||
| Filed 2024-02-06 18:50 Tx date 2024-02-06 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-748,926.78
-72,782 vol $10.29 each |
13,328 | |
| Filed 2024-02-06 18:49 Tx date 2024-02-06 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$235,085
+72,782 vol $3.23 each |
86,110 | |
| Filed 2024-02-06 18:46 Tx date 2024-02-06 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-235,085.86
-72,782 vol $3.23 each |
1,612,500 | |
| Filed 2024-02-06 13:19 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-5,020
-500 vol $10.04 each |
13,328 | |
| Filed 2024-02-06 13:15 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,615
+500 vol $3.23 each |
||
| Filed 2024-02-06 13:15 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,615
+500 vol $3.23 each |
13,828 | |
| Filed 2024-02-06 13:01 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-6,419.50
-694 vol $9.25 each |
13,328 | |
| Filed 2024-01-17 19:38 Tx date 2024-01-16 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-5,549.14
-1,718 vol $3.23 each |
||
| Filed 2024-01-17 19:38 Tx date 2024-01-16 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-5,549.14
-1,718 vol $3.23 each |
1,685,782 | |
| Filed 2024-01-11 16:35 Tx date 2024-01-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-4,270.89
-699 vol $6.11 each |
14,022 | |
| Filed 2022-10-27 14:44 Tx date 2022-06-29 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
1,687,500 | |
| Filed 2021-07-07 16:13 Tx date 2021-07-06 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$12,306
+1,246 vol $9.88 each |
14,721 | |
| Filed 2021-07-04 16:38 Tx date 2021-06-30 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,938
+905 vol $9.88 each |
13,475 | |
| Filed 2020-12-15 15:47 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,400,000
+200,000 vol $7.00 each |
1,597,500 | |
| Filed 2020-12-14 15:49 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,400,000
+200,000 vol $7.00 each |
1,397,500 | |
| Filed 2020-08-04 12:51 Tx date 2020-07-31 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$49,998
+8,333 vol $6.00 each |
12,570 | |
| Filed 2020-07-02 14:19 Tx date 2020-06-29 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$20,718
+4,237 vol $4.89 each |
4,237 | |
| Filed 2020-07-02 14:17 Tx date 2016-08-01 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-16 14:07 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,133,100
+970,000 vol $3.23 each |
1,197,500 | |
| Filed 2019-02-12 Tx date 2019-02-08 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$152,400
+40,000 vol $3.81 each |
227,500 | |
| Filed 2018-04-26 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-3,562,500 vol |
187,500 | |
| Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$58,000
+290,000 vol $0.20 each |
290,000 | |
| Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$750,000
+3,750,000 vol $0.20 each |
||
| Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-1,012,100
-290,000 vol $3.49 each |
0 | |
| Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$692,000
+3,460,000 vol $0.20 each |
3,750,000 | |
| Filed 2016-08-12 Tx date 2016-08-09 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,012,100
+290,000 vol $3.49 each |
290,000 | |
| Filed 2016-08-09 Tx date 2016-08-01 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|